The difference between the treatments proved highly significant in favour of group B over the entire study period (Fig. 7 ).
← all excerpts
Fluticasone furoate/Vilanterol 92/22 μg once-a-day vs Beclomethasone dipropionate/Formoterol 100/6 μg b.I.D.: a 12-month comparison of outcomes in mild-to-moderate asthma.
1
—
—